Paraguay Medical Device Regulation 2026-2029: MERCOSUR Alignment and Regulatory Outlook

1. Key takeaways

1. Resolución GMC N° 25/21 (adopted on October 13, 2021 in Montevideo) is the new-generation MERCOSUR technical regulation for medical device registration and has been transposed into domestic law in some member states (Argentina transposed it in January 2025 through an ANMAT rule, simultaneously replacing GMC 40/00); the transposition status in Paraguay is pending verification against the official DINAVISA publication.
2. Until transposition is completed, the classification rules and dossier requirements in Paraguay follow Resolution 226/2024 and its Annex I.
3. Over the next 12–24 months, five lines should be tracked closely: the annual update of the reference regulatory authority list (Res. 148/2024 and its updates), the fee schedule (Article 35), the implementation of the traceability system (Decreto 3668/2025), the rollout of the sanction discretion methodology (from May 2026), and the adjustment of the conditional use authorization rules (draft amendment to Article 3 of Res. 203/2025 released for public consultation).
4. The only standard for judging any claim that Paraguay has adopted a given regional regulation is a publication on the DINAVISA website or in the official gazette.

2. Legal basis

This is the widest instrument map in the series, because the outlook chapter must span the regional layer and the national layer at once. The MERCOSUR regulation sits at the regional level and produces domestic effect only through transposition, while Res. 148/2024, Resolution 226/2024, Decreto 3668/2025 and the 2026 sanction methodology operate nationally. Any planning document for Paraguay should reference both layers explicitly, with the national layer treated as the operative law until the authority says otherwise.

The watch table recommended below works only if each line is tracked at its natural source: the annual list on the DINAVISA website, the fee schedule in the resolution itself and its amendments, the traceability decree through its implementing releases, the sanction methodology through the official gazette, and the conditional use authorization draft through the public consultation channel. Centralizing the sources in one table, with a column for the last verification date, turns a diffuse monitoring burden into a five-minute weekly routine.

3. Expert insights

Insight one: the gap in legal effect between a regional rule and a domestic rule is the most common judgment error in multinational registrations. A MERCOSUR resolution produces domestic effect only after transposition into the law of each member state. That Argentina has transposed does not mean Paraguay has. Writing regional progress directly into a Paraguay project plan produces systematic errors in the classification rules applied and in the dossier list prepared. The discipline is simple but strict: until DINAVISA publishes the transposition, the operative text in Paraguay is Resolution 226/2024 with Annex I, whatever the regional timeline suggests.

Insight two: three of the five tracking lines directly affect cost and timeline. The annual list determines whether the 45 working day simplified procedure is available; the fee schedule under Article 35 determines the cash cost of filings; and the traceability system under Decreto 3668/2025 determines coding and procurement eligibility. These three are direct inputs into project budgets and schedules and should be reviewed quarterly. The remaining two lines, the sanction methodology and the conditional use authorization draft, shape risk exposure and product strategy, and deserve the same calendar treatment even though their financial effect is less immediate.

Insight three: the direction of institutional evolution in Paraguay is convergence plus tightening. From the 2024 change of regime (10-year validity, electronic processing, the simplified and full procedure split), to the 2025 traceability decree, to the 2026 sanction methodology and border cooperation, the trajectory is consistent: alignment with international standards combined with stronger compliance and enforcement intensity. The right corporate response is not to wait for each step to arrive, but to solidify dossier quality and the post-market system in advance, so that each tightening wave raises competitors’ costs faster than it raises yours.

4. Practical recommendations

1. Maintain a regulatory watch table for Paraguay with one owner and a quarterly review frequency for each of the five tracking lines, so no line depends on a single person’s memory.
2. For every rumor of regional regulation transposition, require an official DINAVISA source; until a source is obtained, continue executing under the current resolution.
3. Treat the annual update of the reference authority list as a fixed annual qualification review point, and re-check simplified procedure eligibility for every project in the pipeline at that moment.
4. Consolidate the post-market system in advance, including the change ledger, the vigilance archive and label consistency, to reduce the remediation cost when future rules tighten.

The phrase pending verification appears twice in this chapter by design. It is the honest status of both the GMC 25/21 transposition and any secondary description of the new sanction method until the authority publishes the texts. Treating pending verification as a scheduled task with an owner, rather than as an admission of ignorance, is what separates a managed regulatory watch from a passive one. The same habit applies to the five tracking lines: every entry in the watch table should record where the information came from and when it was last confirmed.

5. Verification checklist

• □ A regulatory watch table covering the five tracking lines has been established
• □ The transposition status of GMC 25/21 in Paraguay is verified against official publication (absent publication, treat as not transposed)
• □ The annual list has been set as a fixed review point
• □ The fee schedule is checked quarterly
• □ The post-market system (change ledger, vigilance archive, label consistency) has been consolidated

Regulatory information verified as of October 29, 2026.

GRZAN provides registration and post-market compliance support for medical device manufacturers, importers and authorized representatives in Paraguay. For assistance with regulatory horizon scanning or any other regulatory matter, contact info@grzanglobal.com.